Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID

Inclusion Criteria: * Prior confirmed COVID-19 diagnosis by standard RT-PCR assay or equivalent testing * Persistent symptoms that continue four or more weeks after the start of a COVID-19 infection * Quantified autonomic symptoms from at least one domain as reported by the patient on the screener Composite Autonomic Symptom Score (COMPASS-31). The COMPASS-31 assesses 6 domains of autonomic symptoms: Orthostatic Intolerance, Vasomotor, Secretomotor, Gastrointestinal, Bladder, and Pupillomotor. * Quantified pain symptoms of pain interference or pain intensity as reported by the patient on the screener Patient-Reported Outcomes Measurement Information System (PROMIS-29) Exclusion Criteria: * Under age 18 * Prior SGB * Allergy to amide local anesthetics (e.g., ropivacaine, bupivacaine/Marcaine) * Pregnancy * Current anticoagulant use * History of a bleeding disorder * History of glaucoma * Infection or mass at injection site * For the consistency of this study, patients who deny all autonomic symptoms on the COMPASS-31 or pain symptoms on the PROMIS-29 will also be excluded